Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy
Authors
Keywords
Drug resistance, Prodrug, Cancer nanomedicine, Synergetic effect
Journal
BIOMATERIALS
Volume 261, Issue -, Pages 120347
Publisher
Elsevier BV
Online
2020-08-26
DOI
10.1016/j.biomaterials.2020.120347
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunomodulatory Lipocomplex Functionalized with Photosensitizer-Embedded Cancer Cell Membrane Inhibits Tumor Growth and Metastasis
- (2019) Han Young Kim et al. NANO LETTERS
- Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy
- (2019) Wooram Um et al. BIOMATERIALS
- Structural Polymorphism in a Self-Assembled Tri-Aromatic Peptide System
- (2018) Noam Brown et al. ACS Nano
- Reducing Dendrimer Generation and PEG Chain Length Increases Drug Release and Promotes Anticancer Activity of PEGylated Polylysine Dendrimers Conjugated with Doxorubicin via a Cathepsin-Cleavable Peptide Linker
- (2018) Dharmini Mehta et al. MOLECULAR PHARMACEUTICS
- Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation
- (2018) Miles A. Miller et al. ACS Nano
- Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy
- (2018) Man Kyu Shim et al. JOURNAL OF CONTROLLED RELEASE
- Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma
- (2017) Shawn T. Beug et al. Nature Communications
- Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging
- (2016) Man Kyu Shim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- New insights and evolving role of pegylated liposomal doxorubicin in cancer therapy
- (2016) Alberto A. Gabizon et al. DRUG RESISTANCE UPDATES
- Does Nanomedicine Have a Delivery Problem?
- (2016) Michael Torrice ACS Central Science
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Synthesis of a novel, sequentially active-targeted drug delivery nanoplatform for breast cancer therapy
- (2015) Arpan Satsangi et al. BIOMATERIALS
- Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles
- (2015) Shaobo Ruan et al. BIOMATERIALS
- Promises and Challenges of Smac Mimetics as Cancer Therapeutics
- (2015) S. Fulda CLINICAL CANCER RESEARCH
- The Phe-Phe Motif for Peptide Self-Assembly in Nanomedicine
- (2015) Silvia Marchesan et al. MOLECULES
- Principles of nanoparticle design for overcoming biological barriers to drug delivery
- (2015) Elvin Blanco et al. NATURE BIOTECHNOLOGY
- Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients
- (2014) A. L. Wong et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Self-Assembly of Phenylalanine-Based Molecules
- (2014) Helen W. German et al. JOURNAL OF PHYSICAL CHEMISTRY A
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides
- (2013) Wei Gao et al. BIOMATERIALS
- Cathepsin B as a cancer target
- (2013) Christopher S Gondi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Tumor-targeting multi-functional nanoparticles for theragnosis: New paradigm for cancer therapy
- (2012) Ju Hee Ryu et al. ADVANCED DRUG DELIVERY REVIEWS
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Multicenter Phase II Trial of Temozolomide in Mycosis Fungoides/Sezary Syndrome: Correlation with O6-Methylguanine-DNA Methyltransferase and Mismatch Repair Proteins
- (2011) C. Querfeld et al. CLINICAL CANCER RESEARCH
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance
- (2009) Yogesh Patil et al. JOURNAL OF CONTROLLED RELEASE
- WL-276, an Antagonist against Bcl-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth
- (2008) L. Wang et al. CANCER RESEARCH
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now